MDT

96.1

-0.44%↓

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

Начало・Списък с акции・Odonate Therapeutics Inc

O
Odonate Therapeutics Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Odonate Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.12.2025 г., 22:03 ч. UTC

Значими двигатели на пазара

Mining Stocks Slip Near the End of Stellar Year

29.12.2025 г., 15:57 ч. UTC

Значими двигатели на пазара

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29.12.2025 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Decline; Yen in Focus -- Market Talk

29.12.2025 г., 23:38 ч. UTC

Придобивния, сливания и поглъщания

Manus: Will Continue to Operate From Singapore

29.12.2025 г., 23:38 ч. UTC

Придобивния, сливания и поглъщания

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29.12.2025 г., 23:37 ч. UTC

Придобивния, сливания и поглъщания

Meta Platforms: Will Integrate Manus Service Into Products

29.12.2025 г., 23:36 ч. UTC

Придобивния, сливания и поглъщания

Meta Platforms: Will Continue to Operate, Sell Manus Service

29.12.2025 г., 23:36 ч. UTC

Придобивния, сливания и поглъщания

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29.12.2025 г., 23:35 ч. UTC

Придобивния, сливания и поглъщания

Manus to Join Meta Platforms

29.12.2025 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Origin: Raise Values Kraken at US$8.65 Billion

29.12.2025 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Origin: Octopus Targeting Kraken Separation by Mid 2026

29.12.2025 г., 21:31 ч. UTC

Придобивния, сливания и поглъщания

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29.12.2025 г., 21:31 ч. UTC

Придобивния, сливания и поглъщания

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29.12.2025 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

Origin's Kraken Stake to Remain at 22.7%

29.12.2025 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29.12.2025 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29.12.2025 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

Origin: Additional Interest Offsets Dilution From Raise

29.12.2025 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29.12.2025 г., 21:29 ч. UTC

Придобивния, сливания и поглъщания

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29.12.2025 г., 21:29 ч. UTC

Придобивния, сливания и поглъщания

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29.12.2025 г., 21:29 ч. UTC

Придобивния, сливания и поглъщания

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29.12.2025 г., 21:28 ч. UTC

Придобивния, сливания и поглъщания

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29.12.2025 г., 21:28 ч. UTC

Придобивния, сливания и поглъщания

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29.12.2025 г., 21:28 ч. UTC

Придобивния, сливания и поглъщания

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29.12.2025 г., 21:28 ч. UTC

Придобивния, сливания и поглъщания

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29.12.2025 г., 21:27 ч. UTC

Придобивния, сливания и поглъщания

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29.12.2025 г., 20:22 ч. UTC

Пазарно говорене

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29.12.2025 г., 20:14 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29.12.2025 г., 20:02 ч. UTC

Придобивния, сливания и поглъщания

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29.12.2025 г., 17:36 ч. UTC

Пазарно говорене

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Odonate Therapeutics Inc Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

Относно Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.